Rankings
▼
Calendar
ATYR Q4 2016 Earnings — aTyr Pharma, Inc. Revenue & Financial Results | Market Cap Arena
ATYR
aTyr Pharma, Inc.
$89M
Q4 2016 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$13M
Net Income
-$13M
EPS (Diluted)
$-7.42
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$12M
Free Cash Flow
-$12M
Stock-Based Comp.
$1M
Balance Sheet
Total Assets
$81M
Total Liabilities
$18M
Stockholders' Equity
$63M
Cash & Equivalents
$38M
← FY 2016
All Quarters
Q1 2017 →
